Intraoperative hyperthermic chemotherapy perfusion for malignant pleural mesothelioma: An in vitro evaluation  Robert B. Cameron, MD, Dongmei Hou, PhD 

Slides:



Advertisements
Similar presentations
Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Advertisements

Manuel J. Antunes, MD, PhD, DSc 
Surgery for congenital diseases of the aorta
Neel R. Sodha, MD, Frank W. Sellke, MD 
Building a bioartificial heart: A 3-song saga
Intrinsic cardiac stem cells are essential for regeneration
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Simulation of single-ventricle physiology … a start
Abracadabra I, II…HeartMate 3?
Victor van Berkel, MD, PhD 
William M. DeCampli, MD, PhD 
How should we treat air leaks?
New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum  Martin Czerny, MD, MBA  The Journal.
Bicuspid aortic valve aortopathy: One size fits all?
What is the best approach for surgery of malignant pleural mesothelioma? It is to put our efforts into obtaining trustworthy evidence for practice  Tom.
Left ventricular apical papillary fibroelastoma
Bigger The Journal of Thoracic and Cardiovascular Surgery
The lord of the rings  Antonio Miceli, MD, PhD 
The unintended consequences in clinical research
Aldo R. Castañeda, MD, PhD: Recipient of the Lifetime Achievement Award and 74th president of The American Association for Thoracic Surgery  Pedro J.
STAT3, Cten, and lung cancer: Simultaneous excitement and caution
The variability of the mitral valve anatomy and terminology
Yang Zhang, MD, Haiquan Chen, MD, PhD 
Support Your Specialty
Innovation and science: The future of valve design
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
Military surgeons just want to have fun
A first start for lung transplantation?
Confusion still exists regarding postoperative delirium and its etiology after esophagectomy  Robert B. Cameron, MD  The Journal of Thoracic and Cardiovascular.
Shawn S. Groth, MD, MS, R. Taylor Ripley, MD, Bryan M. Burt, MD 
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Historical perspectives of The American Association for Thoracic Surgery: Robert M. Janes, MD ( )  Myunghyun Lee, MD, Vivek Rao, MD, PhD  The.
Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow?  Jules Lin, MD  The Journal of Thoracic and Cardiovascular.
Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD 
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
Frank C. Spencer, MD, FACS, pioneering cardiothoracic surgeon
Instrumental variable methods in clinical research
A fate worse than death  Jennifer S. Lawton, MD 
Attachment disorder in thoracoabdominal surgery
Uma M. Sachdeva, MD, PhD, Daniela Molena, MD 
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
The thoracoabdominal saga and heroes
T. Brett Reece, MD  The Journal of Thoracic and Cardiovascular Surgery 
If airlines can do it, we can too…
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
Bryan M. Burt, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Ventricular assistant in restrictive cardiomyopathy: Making the right connection  Robert D.B. Jaquiss, MD  The Journal of Thoracic and Cardiovascular Surgery 
The continuing challenge of congenital heart disease in China
Bicuspid aortopathy: Seeing the forest for the trees
Ralph E. Delius, MD  The Journal of Thoracic and Cardiovascular Surgery 
Therapeutic R2 resection for pleural mesothelioma
The Journal of Thoracic and Cardiovascular Surgery
“The more things change…”: The challenges ahead
Evaluating the best approach to treatment of aortic stenosis: The jury is still out  Glen B. Taksler, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Managing conflicts of interest
First in line for robotic surgery: Would you want to know?
Aritoshi Hattori, MD, Kenji Suzuki, MD 
Preoperative PFTs: The answer is blowing in the wind
Of mice and men… The Journal of Thoracic and Cardiovascular Surgery
Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found? 
Did you like Terminator 3 better than Terminator 2
Samuel Kim, MD  The Journal of Thoracic and Cardiovascular Surgery 
How do we follow up our patients
Journal changes and initiatives
Calpain inhibitors: The aspirin of the 21st century?
Deciding how much to pay for effective care
Presentation transcript:

Intraoperative hyperthermic chemotherapy perfusion for malignant pleural mesothelioma: An in vitro evaluation  Robert B. Cameron, MD, Dongmei Hou, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 145, Issue 2, Pages 496-504 (February 2013) DOI: 10.1016/j.jtcvs.2012.10.042 Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Dose-response relationship for time and temperature. The response of CHO-K1, NCI-H28, and A549 cell lines to varying degrees of heat (37°C, 42°C, and 45°C) for varying time periods (0, 20, 40, and 60 minutes) is shown. The t test statistics are included where the results were statistically significant compared with the no treatment control cultures at a P value less than .001. CHO, Chinese hamster ovary. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 496-504DOI: (10.1016/j.jtcvs.2012.10.042) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Dose-response relationship for time at 42°C for various cell lines. The response of CHO-K1, MRC-5, A549, NCI-H28, NCI-H2052, and MSTO-211H cell lines to varying time periods (0, 20, 40, and 60 minutes) at 42°C is shown. The t test statistics are included where the results were statistically significant compared with the no treatment control cultures at a P value less than .001. CHO, Chinese hamster ovary. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 496-504DOI: (10.1016/j.jtcvs.2012.10.042) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Hyperthermic chemotherapy with cisplatin. The response of CHO-K1, MRC-5, A549, NCI-H28, NCI-H2052, and MSTO-211H cell lines to varying doses of cisplatin chemotherapy combined with hyperthermia (42°C) is shown. Of note, the reduction of cell viability mediated by chemotherapy (variation between different shaded bars) was greater than that seen with hyperthermia (variation between similar shaded bars). Although almost all findings were “statistically significant,” the differences would be clinically meaningless. CHO, Chinese hamster ovary. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 496-504DOI: (10.1016/j.jtcvs.2012.10.042) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Hyperthermic chemotherapy with multiagent chemotherapy. The response of CHO-K1, MRC-5, A549, NCI-H28, NCI-H2052, and MSTO-211H cell lines to varying doses of combination chemotherapy with cisplatin + pemetrexed (A) or cisplatin + gemcitabine (B), both with hyperthermia, (42°C) is shown. Of note, the reduction of cell viability mediated by chemotherapy (variation between different shaded bars) was greater than that seen with hyperthermia (variation between similar shaded bars). Although almost all findings were “statistically significant,” the differences would be clinically meaningless. CHO, Chinese hamster ovary. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 496-504DOI: (10.1016/j.jtcvs.2012.10.042) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions